emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

UniPhar / Hickey's Pharmacy Group

No EMAT : 110427
Announced Date : 01/09/2020
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : UniPhar

Target : Hickey's Pharmacy Group
Country : Ireland
Sector of activity :
  • Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
Business Description :
Hickey's Pharmacy Group is Ireland’s fifth largest retail pharmacy chain. > Operate 36 retail pharmacies in the State. > Also operate a wholesale business, procuring drugs from pharmaceutical...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic ns
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Drugs Retailers » = 51
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
20/09/2022 UniPhar LXV Remedies Holdings (McCauley Pharmacy Group) Ireland * 110405
30/06/2021 Europris Lekekassen Norway ** 109301

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report